1,3-distearyl-2-octanoylglycerol has been researched along with Exocrine Pancreatic Insufficiency in 1 studies
*Exocrine Pancreatic Insufficiency: A malabsorption condition resulting from greater than 10% reduction in the secretion of pancreatic digestive enzymes (LIPASE; PROTEASES; and AMYLASE) by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bożek, M; Jonderko, K; Piłka, M | 1 |
1 other study(ies) available for 1,3-distearyl-2-octanoylglycerol and Exocrine Pancreatic Insufficiency
| Article | Year |
|---|---|
On a refinement of the ¹³C-mixed TAG breath test.
Topics: Adult; Breath Tests; Carbon Isotopes; Dietary Fats; Exocrine Pancreatic Insufficiency; Feasibility Studies; Female; Humans; Kinetics; Male; Pancreas, Exocrine; Postprandial Period; Triglycerides | 2012 |